Provided by Tiger Trade Technology Pte. Ltd.

CG Oncology Inc.

78.73
-1.0800-1.35%
Volume:312.11K
Turnover:24.62M
Market Cap:6.98B
PE:-28.91
High:79.89
Open:79.44
Low:77.59
Close:79.81
52wk High:80.97
52wk Low:25.25
Shares:88.64M
Float Shares:64.73M
Volume Ratio:0.48
T/O Rate:0.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7235
EPS(LYR):-2.0826
ROE:-26.41%
ROA:-17.67%
PB:6.78
PE(LYR):-37.80

Loading ...

Analysts’ Top Healthcare Picks: Spruce Biosciences (SPRB), CG Oncology, Inc. (CGON)

TIPRANKS
·
May 27

Alec Stranahan Reiterates Buy on CG Oncology, Lifts Price Target to $87 as Commercialization Plans Stay on Track

TIPRANKS
·
May 27

CG Oncology Chief Operating Officer Ambaw Bellete to Depart

MT Newswires Live
·
May 26

CG Oncology announces departure of president, COO Ambaw Bellete

TIPRANKS
·
May 26

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Olema Pharmaceuticals (OLMA) and CG Oncology, Inc. (CGON)

TIPRANKS
·
May 26

Wolfe sees CG Oncology COO exit as operational, no impact to key programs

TIPRANKS
·
May 26

CG Oncology Inc - Appoints Arthur Kuan as President - SEC Filing

THOMSON REUTERS
·
May 26

CG Oncology - Ambaw Bellete to Separate From Co as President & COO Effective June 30 - SEC Filing

THOMSON REUTERS
·
May 26

CG Oncology names Arthur Kuan president after COO Ambaw Bellete exits

Reuters
·
May 26

CG Oncology Initiated at Peer Perform by Wolfe Research

Dow Jones
·
May 19

SUO-CTC and CG Oncology Announce Award Recipients of the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award

GlobeNewswire
·
May 19

CG Oncology initiated with a Peer Perform at Wolfe Research

TIPRANKS
·
May 19

CG Oncology's Creto Combination Could Drive Better Efficacy in BCG-Exposed NMIBC, UBS Says

MT Newswires Live
·
May 18

Wedbush Remains a Buy on CG Oncology, Inc. (CGON)

TIPRANKS
·
May 18

CG Oncology Price Target Maintained With a $100.00/Share by HC Wainwright & Co.

Dow Jones
·
May 18

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Insulet (PODD), ProKidney (PROK) and CG Oncology, Inc. (CGON)

TIPRANKS
·
May 18

CG Oncology, Inc. (CGON) Receives a Rating Update from a Top Analyst

TIPRANKS
·
May 16

CG Oncology reports first results from CORE-008 Cohort CX

TIPRANKS
·
May 15

CG Oncology Reports 'Encouraging' Data From Study of Intravesical Combination Therapy to Treat Bladder Cancer

MT Newswires Live
·
May 15

CG Oncology reports Phase 2 CORE-008 combo trial posts 92.3% complete response rate

Reuters
·
May 15